China in talks with WHO over global use of Covid-19 vaccines

Published October 7, 2020
A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus  vaccine, during a government-organised media tour in Beijing, China, September 24, 2020. — Reuters
A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus vaccine, during a government-organised media tour in Beijing, China, September 24, 2020. — Reuters

SINGAPORE: China is in talks to have its locally-produced Covid-19 vaccines assessed by the World Health Organisation, as a step towards making them available for international use, a WHO official said on Tuesday.

Hundreds of thousands of essential workers and other groups considered at high risk in China have been given locally-developed vaccines even as clinical trials had not been fully completed, raising safety concerns among experts.

Socorro Escalate, WHO’s coordinator for essential medicines and health technologies in the Western Pacific region, told a news conference conducted online that China had held preliminary discussions with WHO to have its vaccines included in a list for emergency use.

The WHO’s emergency use listing procedure allows unlicensed vaccines and treatments to be assessed to expedite their availability in public health emergencies. This helps WHO member states and UN procurement agencies to determine the acceptability of the vaccines.

“Potentially through this emergency use listing the quality and safety of these vaccines and efficacy could be assessed... and then this could be made available for our licensees,” Escalante said.

China has at least four experimental vaccines in the final stage of clinical trials — two are developed by state-backed China National Biotec Group (CNBG), and the remaining two are from Sinovac Biotech and CanSino Biologics respectively. They are tested in such countries as Pakistan, Indonesia, Brazil, Russia and the United Arab Emirates.

Last month, the UAE authorised the emergency use of a CNBG vaccine, the first international emergency clearance for one of China’s vaccines, just six weeks after human trials began in the Gulf Arab state.

Published in Dawn, October 7th, 2020

Opinion

Editorial

Kurram atrocity
22 Nov, 2024

Kurram atrocity

WITH the situation in KP’s Kurram tribal district already volatile for the past several months, the murderous...
Persistent grip
22 Nov, 2024

Persistent grip

PAKISTAN has now registered 50 polio cases this year. We all saw it coming and yet there was nothing we could do to...
Green transport
22 Nov, 2024

Green transport

THE government has taken a commendable step by announcing a New Energy Vehicle policy aiming to ensure that by 2030,...
Military option
Updated 21 Nov, 2024

Military option

While restoring peace is essential, addressing Balochistan’s socioeconomic deprivation is equally important.
HIV/AIDS disaster
21 Nov, 2024

HIV/AIDS disaster

A TORTUROUS sense of déjà vu is attached to the latest health fiasco at Multan’s Nishtar Hospital. The largest...
Dubious pardon
21 Nov, 2024

Dubious pardon

IT is disturbing how a crime as grave as custodial death has culminated in an out-of-court ‘settlement’. The...